ReviewCancer management and research2021

The Evolving Role of FGFR2 Inhibitors in Intrahepatic Cholangiocarcinoma: From Molecular Biology to Clinical Targeting.

Massimiliano Salati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.